Virtual Reality Intervention for Skill Acquisition Support in Autism Spectrum Disorder (ASD)
A Randomized Controlled Phase II Study to Assess the Efficacy of Floreo VR Building Social Connections vs. Active VR Exposure Control as Treatment for Social Skills in Autistic Children
1 other identifier
interventional
30
1 country
1
Brief Summary
A Randomized Controlled Phase II study to assess the efficacy of Floreo VR (Virtual reality) Building Social Connections as treatment for social skills in children with Autism Spectrum Disorder (ASD)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Feb 2023
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2023
CompletedFirst Submitted
Initial submission to the registry
February 27, 2023
CompletedFirst Posted
Study publicly available on registry
March 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 29, 2023
CompletedFebruary 26, 2025
February 1, 2025
4 months
February 27, 2023
February 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Autism Impact Measure (AIM) Assessment
The AIM is a 25-item parent questionnaire targeting sensitivity to change of core ASD symptoms. The questionnaire uses a 2-week recall period with items rated on two corresponding 5-point scales (frequency and impact). The items cover distinct sub-domains of ASD symptoms including Repetitive Behavior, Atypical Behavior, Social Reciprocity, and Peer Interaction. A composite score is also calculated.
The AIM takes approximately 30 minutes to complete.
Secondary Outcomes (1)
CARS-2
The CARS-3 takes approximately 5-10 minutes to complete after the information needed to make the ratings is collected
Other Outcomes (3)
AIM sub-domain scores
The AIM takes approximately 30 minutes to complete.
Vineland-3 Adaptive Behavior Composite and sub-domain scores
The Vineland-3 Comprehensive Interview Form takes approximately 60-90 minutes to complete
Adverse events related to VR use
5-10 minutes as needed to fill out AE form
Study Arms (2)
Floreo VR Building Social Connections
EXPERIMENTALParticipants will receive Floreo VR Building Social Connections lessons approximately 3 times a week for no more than 15 minutes per session.
Sham
SHAM COMPARATORParticipants will receive non-interventional active VR videos approximately 3 times a week for no more than 15 minutes per session.
Interventions
Floreo's VR platform consists of a VR headset and wireless tethered VR screens (iPhones) and tablets (iPads) that are seamlessly linked in real time, allowing the therapist (or monitor) to set up lessons, change the interactive environment, and provide live verbal and VR-based guidance, feedback, and rewards to users. The lessons that will be implemented in this intervention are aimed at targeting social skills such as communication, joint attention, and social interactions.
This condition will contain the same VR headset and wireless tethered VR screens (iPhones) and tablets (iPads) as the intervention condition, but instead of social skill lessons, only non-intervention, active VR videos such as underwater fish swimming will be shown.
Eligibility Criteria
You may qualify if:
- Males and females aged 4 years to 10 years 11 months of age (up to 11th birthday at randomization).
- Patients or legally authorized representatives must provide written informed consent and be willing and able to comply with study procedures. Participants must provide informed assent as clinically appropriate.
- A diagnosis of autism spectrum disorder on the basis of the clinical judgement of a qualified clinician according to DSM-5 criteria, supported by either the Autism Diagnostic Observation Schedule or the Autism Diagnostic Interview-Revised.
- Participants must receive ABA therapy at Cortica, with scheduled ABA sessions in clinic at least 3 times per week.
- Participants must be able to tolerate VR therapy in the judgement of parent or caregiver and study staff
You may not qualify if:
- A history of photosensitive epilepsy, or photoparoxysmal response on electroencephalogram (EEG)
- Active diagnosis of migraine headache or migraine variant (abdominal migraine, cyclic vomiting syndrome), not adequately controlled
- History of balance disorder including vertigo, motion sensitivity, or balance disorder
- Primary sensory impairment (blindness, deafness)
- Motor disorder that would interfere with VR engagement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Floreo, Inc.lead
- Corticacollaborator
Study Sites (1)
Cortica
Thousand Oaks, California, 91361, United States
Related Publications (1)
Kanne SM, Mazurek MO, Sikora D, Bellando J, Branum-Martin L, Handen B, Katz T, Freedman B, Powell MP, Warren Z. The Autism Impact Measure (AIM): initial development of a new tool for treatment outcome measurement. J Autism Dev Disord. 2014 Jan;44(1):168-79. doi: 10.1007/s10803-013-1862-3.
PMID: 23748386BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Subjects and their parents/caregivers will be blinded to whether they are receiving Floreo VR therapy vs active VR exposure control. Research staff administering the therapy or control will not be blinded to the therapy; however, the clinicians doing pre/post assessments will be blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2023
First Posted
March 30, 2023
Study Start
February 15, 2023
Primary Completion
June 29, 2023
Study Completion
June 29, 2023
Last Updated
February 26, 2025
Record last verified: 2025-02